
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 379919
[patent_doc_number] => 07309490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-18
[patent_title] => 'Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response'
[patent_app_type] => utility
[patent_app_number] => 11/198323
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6768
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/309/07309490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198323
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198323 | Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response | Aug 7, 2005 | Issued |
Array
(
[id] => 5520905
[patent_doc_number] => 20090028886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Carrier conjugates of gnrh-peptides'
[patent_app_type] => utility
[patent_app_number] => 11/659221
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27569
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659221
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659221 | Carrier conjugates of gnrh-peptides | Aug 3, 2005 | Abandoned |
Array
(
[id] => 5246969
[patent_doc_number] => 20070243203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Vaccine for Prevention and Treatment of Hiv-Infection'
[patent_app_type] => utility
[patent_app_number] => 11/573128
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14796
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243203.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573128 | Vaccine for prevention and treatment of HIV-infection | Aug 2, 2005 | Issued |
Array
(
[id] => 5880533
[patent_doc_number] => 20060029615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Novel recombinant T4 phage particle and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/188236
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14802
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029615.pdf
[firstpage_image] =>[orig_patent_app_number] => 11188236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/188236 | Novel recombinant T4 phage particle and uses thereof | Jul 21, 2005 | Abandoned |
Array
(
[id] => 5434917
[patent_doc_number] => 20090169503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'DNA-BASED VACCINATION OF RETROVIRAL-INFECTED INDIVIDUALS UNDERGOING TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 11/571879
[patent_app_country] => US
[patent_app_date] => 2005-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25392
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169503.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571879 | DNA-BASED VACCINATION OF RETROVIRAL-INFECTED INDIVIDUALS UNDERGOING TREATMENT | Jul 10, 2005 | Abandoned |
Array
(
[id] => 6220574
[patent_doc_number] => 20100055669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Generation of Recombinant Genes in Bacteriophages'
[patent_app_type] => utility
[patent_app_number] => 11/570608
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10163
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055669.pdf
[firstpage_image] =>[orig_patent_app_number] => 11570608
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/570608 | Generation of Recombinant Genes in Bacteriophages | Jul 5, 2005 | Abandoned |
Array
(
[id] => 7069000
[patent_doc_number] => 20050244383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Method and device for sanitation using bacteriophages'
[patent_app_type] => utility
[patent_app_number] => 11/173082
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21089
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11173082
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/173082 | Method and device for sanitation using bacteriophages | Jun 30, 2005 | Abandoned |
Array
(
[id] => 10892564
[patent_doc_number] => 08916175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-23
[patent_title] => 'Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection'
[patent_app_type] => utility
[patent_app_number] => 11/630147
[patent_app_country] => US
[patent_app_date] => 2005-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10572
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11630147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630147 | Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection | Jun 21, 2005 | Issued |
Array
(
[id] => 6925404
[patent_doc_number] => 20050238659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Vaccine and method of use'
[patent_app_type] => utility
[patent_app_number] => 11/158652
[patent_app_country] => US
[patent_app_date] => 2005-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10145
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238659.pdf
[firstpage_image] =>[orig_patent_app_number] => 11158652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/158652 | Vaccine and method of use | Jun 21, 2005 | Abandoned |
Array
(
[id] => 4872759
[patent_doc_number] => 20080199493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors'
[patent_app_type] => utility
[patent_app_number] => 11/597457
[patent_app_country] => US
[patent_app_date] => 2005-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28086
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199493.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597457 | Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors | May 24, 2005 | Abandoned |
Array
(
[id] => 5045611
[patent_doc_number] => 20070264284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B'
[patent_app_type] => utility
[patent_app_number] => 11/597063
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23656
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597063
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597063 | Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B | May 18, 2005 | Abandoned |
Array
(
[id] => 4903922
[patent_doc_number] => 20080113335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Novel Hiv-Based Recombinant Viral Clones and Use Thereof in Analytical Methods'
[patent_app_type] => utility
[patent_app_number] => 11/596259
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10523
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596259 | Novel Hiv-Based Recombinant Viral Clones and Use Thereof in Analytical Methods | May 9, 2005 | Abandoned |
Array
(
[id] => 7591164
[patent_doc_number] => 07662921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Methods of treating viral disorders'
[patent_app_type] => utility
[patent_app_number] => 11/578391
[patent_app_country] => US
[patent_app_date] => 2005-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11142
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662921.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578391 | Methods of treating viral disorders | May 8, 2005 | Issued |
Array
(
[id] => 7216908
[patent_doc_number] => 20050260220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Recombinant therapeutic fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/124971
[patent_app_country] => US
[patent_app_date] => 2005-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5508
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124971
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124971 | Recombinant therapeutic fusion proteins | May 8, 2005 | Issued |
Array
(
[id] => 5533038
[patent_doc_number] => 20090232826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2'
[patent_app_type] => utility
[patent_app_number] => 11/919698
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9867
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232826.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919698 | Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 | May 1, 2005 | Abandoned |
Array
(
[id] => 7216496
[patent_doc_number] => 20050260168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Compositions comprising viruses and methods for concentrating virus preparations'
[patent_app_type] => utility
[patent_app_number] => 11/116944
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116944
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116944 | Compositions comprising viruses and methods for concentrating virus preparations | Apr 26, 2005 | Abandoned |
Array
(
[id] => 5130769
[patent_doc_number] => 20070207166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Method of Using Adenoviral Vectors to Induce an Immune Response'
[patent_app_type] => utility
[patent_app_number] => 11/578096
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24968
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207166.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578096 | Method of Using Adenoviral Vectors to Induce an Immune Response | Apr 11, 2005 | Abandoned |
Array
(
[id] => 4867440
[patent_doc_number] => 20080146499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12'
[patent_app_type] => utility
[patent_app_number] => 10/599734
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11287
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146499.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599734
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599734 | Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12 | Apr 10, 2005 | Abandoned |
Array
(
[id] => 5794256
[patent_doc_number] => 20060014937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Humanized antibody against S-surface antigen of hepatitis B virus'
[patent_app_type] => utility
[patent_app_number] => 11/100553
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7005
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014937.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100553 | Humanized antibody against S-surface antigen of hepatitis B virus | Apr 6, 2005 | Issued |
Array
(
[id] => 8177622
[patent_doc_number] => 08178657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins'
[patent_app_type] => utility
[patent_app_number] => 11/547399
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 38
[patent_no_of_words] => 24056
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547399 | Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins | Mar 29, 2005 | Issued |